adenosine and fk 838
adenosine has been researched along with fk 838 in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Arima, S; Endo, Y; Ito, O; Ito, S; Omata, K; Takeuchi, K; Yaoita, H | 1 |
| Fujita, M; Ito, H; Kohno, Y; Masamune, A; Satoh, A; Satoh, K; Shimosegawa, T; Toyota, T | 1 |
| Arima, S; Carretero, OA; Ito, S; Ren, Y | 1 |
| Fujii, T; Kinoshita, T; Kuno, M; Nakamura, K; Nakanishi, I; Nishio, N; Sato, A; Seki, N; Terasaka, T; Tsujimoto, S | 1 |
Other Studies
4 other study(ies) available for adenosine and fk 838
| Article | Year |
|---|---|
[Effect of adenosine on isolated afferent arterioles].
Topics: Adenosine; Animals; Arterioles; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney; Male; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rabbits; Theobromine; Vasoconstriction; Vasodilation; Vasodilator Agents; Xanthines | 1999 |
Activation of adenosine A1-receptor pathway induces edema formation in the pancreas of rats.
Topics: Acute Disease; Adenosine; Amylases; Animals; Ceruletide; Edema; Leukocytes; Male; Pancreas; Pancreatic Diseases; Pancreatitis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rats; Rats, Wistar; Receptor, Adenosine A3; Receptors, Purinergic P1; Taurocholic Acid | 2000 |
Possible role of adenosine in macula densa control of glomerular hemodynamics.
Topics: Adenosine; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Juxtaglomerular Apparatus; Kidney Glomerulus; Male; Microcirculation; Microscopy, Video; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rabbits; Receptors, Purinergic P1; Renal Circulation; Sodium Chloride; Vasoconstriction; Vasodilator Agents | 2002 |
Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938.
Topics: Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Anti-Inflammatory Agents; B-Lymphocytes; Cell Line; Collagen Type II; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hypersensitivity, Delayed; Imidazoles; Interleukin-10; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Models, Animal; Naphthalenes; Pyrazoles; Pyridines; Receptors, Adenosine A2; Recombinant Proteins; Tumor Necrosis Factor-alpha | 2006 |